|
The following protocols are now available through Valley’s Office of Cardiac Clinical Trials. Please call Kathleen Sayles at 201-447-8453 for more information.
ACUITY: A randomized comparison of Angiomax (bivalirudin) versus Lovenox/Clexane (enoxaparin) in patients undergoing early invasive management for acute coronary syndromes without ST-segment elevation.
Principal Investigator: Cary Hirsch. MD
Co-investigators: Arivind Agarwal, MD; David Brogno, MD; Michael Kesselbrenner, MD; William Lee, MD; Dennis Reison, MD; Robert Saporito, MD; Janet Strain, MD.
* * * * * * * * * *
ADHERE: Longitudinal module -- registry of severe heart failure patients at high risk for rehospitalization.
Principal Investigator: John Strobeck, MD
Co-investigators: Robert Berkowitz, MD
* * * * * * * * * *
ASPEN –ICD: AF Suppression Pacing to Prevent First Episode of Atrial Fibrillation in High Risk Patients with an Implantable Cardioverter Defibrillator,
Principal Investigator: Margot Vloka, MD
Co-investigators: Jonathan Steinberg, MD; Walter Pierce, MD; Avi Fischer, MD; Frederick Elhert, MD.
* * * * * * * * * *
EARLY ACS: Glycoprotein Iib/IIIa Inhibition in Non-ST-segment Elevation Acute Coronary Syndrom; A Randomized, Placebo-Controlled Trial Evaluating the Clinical Benefits of Early Front-Loaded Eptifibatide in the Treatment of Patients with Non-ST-segment Elevation,
Principal Investigator: Michael Kesselbrenner, MD
Co-investigators: Robert A. Saporito, Jr., MD; and Alan Simon, MD
* * * * * * * * * *
ENDEAVOR: Medtronic DES vs TAXUS. A Randomized, Controlled Trial of the Medtronic Endeavor (ABT-578) Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions.
Principal Investigator: Janet Strain, MD
Co-investigators: Cary Hirsch, MD; Arvind Agarwal, MD; Michael Kesselbrenner, MD; Dennis Reison, MD.
* * * * * * * * * *
EVEREST: Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long Term Efficacy and Safety of Oral Tolvaptan Tablets in Subjects Hospitalized with Worsening Congestive Heart Failure.
Principal Investigator: Michael Kesselbrenner, MD
Co-investigators: Stephen Blumberg, MD; Cary Hirsch, MD; Janet Strain, MD; Howard Goldschmidt, MD; Robert Saporito, MD; Alan Simon, MD; John Pantazopoulos, MD.
* * * * * * * * * *
FREEDOM: Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease.
Principal Investigator: Cary Hirsch, MD at the Valley Hospital
Co-investigators: Dennis Reison, MD; Janet Strain, MD; Arvind Agarwal, MD; Eric Bronstein, MD; Bruce Mindich, MD.
* * * * * * * * * *
HF ACTION: Protocol for Heart Failure and A controlled Trial Investigating Outcomes of Exercise Training
Principal Investigator: Michael Kesselbrenner, MD
Co-investigators: Howard Goldschmidt, MD; Michael Mentakis, MD; Thomas Molloy, MD; John Strobeck, MD; Mark Kirshenbaum, MD; Marcus Williams, MD; John Co, MD.
* * * * * * * * * *
HORIZONS AMI TRIAL: Harmonizing Outcomes with Revascularization and Stents.
Principal Investigator: Cary Hirsch, MD
Co-investigators: Janet Strain, MD; Arvind Agarwal, MD; Dennis Reison, MD; Michael Kesselbrenner, MD.
* * * * * * * * * *
IMPACT OF PULMONARY VEIN ABLATION ON QUALITY OF LIFE IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION
Principal Investigator: Jonathan Steinberg, MD
Co-investigators: Margot Vloka, MD; Frederick Elhert, MD; Avi Fischer, MD; Walter Pierce, MD.
* * * * * * * * * *
IMPROVE-IT: A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin (Ezetimibe/Simvastatin Tablet) vs Simvastatin Monotherapy in High Risk Subjects Presenting with Acute Coronary Syndrome (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
Principal Investigator: Michael Kesselbrenner, MD
Co-investigators: Robert A. Saporito, Jr., MD; Alan Simon, MD; Arvind Agarwal, MD; Cary Hirsch, MD; Dennis Reison, MD; Janet Strain, MD; John Pantazopoulos, MD; Howard Goldschmidt, MD; Navin Budhwani, MD.
* * * * * * * * * *
LIFEWATCH: The Use of the LifeWatch LifeStar AF Express to Detect Asymptomatic AF following PV Ablation
Principal Investigator: Jonathan Steinberg, MD
Co-investigators: Margot Vloka, MD; Frederick Elhert, MD; Avi Fischer, MD; Walter Pierce, MD; Margot Vloka, MD; Sandeep Joshi, MD.
* * * * * * * * * *
MOSAIC: Bioprostheses Aortic Model 305 vs. Carpentier-Edwards Perimount Models 2700 & 2800 -- A Controlled Randomized Trial.
Principal Investigator: Bruce Mindich, MD
Co-investigators: Eric Bronstein, MD; Carlos O. Urrutia-S, MD; Jason S. Sperling, MD
* * * * * * * * * *
PARTNERS HF: - Multi-site Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients with Heart Failure.
Principal Investigator: Margot Vloka, MD
Co-investigators: Jonathan Steinberg, MD; Avi Fischer, MD; Frederick Elhert, MD; Walter Pierce, MD.
* * * * * * * * * *
RESOLVE AF: Surgery for Atrial Fibrillation through Ablative Microwave Intervention
Principal Investigator: Eric Bronstein, MD
Co-Investigators: Bruce Mindich, MD; Jason Sperling, MD; Carlos Urrutia O-S, MD
* * * * * * * * * *
RESPONSE HF: Cardiac Resynchronization Therapy (CRT)
Principal Investigator: Margot Vloka, MD
Co-investigators: Jonathan Steinberg, MD; Walter Pierce, MD; Avi Fischer, MD; Marcus Williams, MD.
* * * * * * * * * *
Risk Stratification in MADIT II Type Patients
Principal Investigator: Margot Vloka, MD
Co-investigators: Jonathan Steinberg, MD; Frederick Elhert, MD; Avi Fischer, MD; Walter Pierce, MD.
* * * * * * * * * *
SPIRIT III: A Randomzed, Multi-center, Clinical Trial Evaluation the Safety and Efficacy of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de nove Native Coronary Artery Lesions
Principal Investigator: Cary Hirsch, MD
Co-investigators: Arvind Agarwal, MD; Michael Kesselbrenner, MD; Dennis Reison, MD; Janet strain, MD
* * * * * * * * * *
STRADIVARIUS: Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant – The Intravascular Ultrasound Study
Principal Investigator: Cary Hirsch, MD
Co-investigators: Dennis Reison, MD; Janet Strain, MD; Michael Kesselbrenner, MD; Arvind Agarwal, MD; David Brogno, MD
* * * * * * * * * *
TIMI 38 Triton 38 - PrAsUgRel vs Plavix: A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention.
Principal investigator: Michael Kesselbrenner, MD
|
|
